Thanks JPGuru
I've found this indicating probably a more current target market size in pancreatic cancer, closer to 500,000 atm.
https://www.wcrf.org/cancer-trends/pancreatic-cancer-statistics/
Most cases appear to be in Hungary, or at least a higher incidence.
Bile duct cancer, another target area for the device is smaller but non the less another indication
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK, page-40
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $56.50K | 4.041M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 12011630 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 6141425 | 9 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |